SIG
EW icon

Stanford Investment Group’s Edwards Lifesciences EW Stock Holding History

Stanford Investment Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,278
Closed -$40K – 90
2016
Q4 		$40K Buy
1,278
+210
+20% +$6.8K 0.02% 162
2016
Q3 		$43K Buy
1,068
+144
+16% +$5.42K 0.02% 166
2016
Q2 		$31K Hold
924
– – 0.02% 196
2016
Q1 		$27K Hold
924
– – 0.02% 206
2015
Q4 		$24K Hold
924
– – 0.01% 200
2015
Q3 		$22K Buy
+924
New +$22.3K 0.02% 211

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Stanford Investment Group's EW Position: Q1 2017 in Review

Stanford Investment Group sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 1,278 shares — an estimated $40K sold.

Stanford Investment Group first reported a position in EW in Q3 2015 and held it in 6 quarters. The position peaked at $43K in Q3 2016. 691 funds tracked by Wall St. Rank hold EW as of Q1 2017.

  • Stanford Investment Group reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 1,278 Edwards Lifesciences shares in Q1 2017, an estimated $40K.
  • Stanford Investment Group first reported a position in Edwards Lifesciences in Q3 2015 and held it in 6 quarters.
  • Stanford Investment Group's Edwards Lifesciences position peaked at $43K in Q3 2016.
  • 691 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.